Nicola La Monica
Senior Director Infectious Disease Scientific Innovation
Why I'm a JPAL
Great opportunity to interact with entrepreneurs, to learn about new approaches and technologies.
Nicola La Monica joined Janssen, Pharmaceutical Companies of Johnson and Johnson as Senior Director of the Infectious Disease & Vaccines Therapeutic Area at the Boston Innovation Center. In this role, he works with external collaborators to drive innovation around novel approaches to infectious disease and vaccine research and development. A biologist with more than 25 years of experience in large pharmaceutical and biotech companies, Nicola has successfully led drug discovery efforts for the treatment of Hepatitis C virus infections and oncology, as well as development programs for cancer immunotherapy. Prior to joining Janssen, Nicola was Vice President at Idera Pharmaceuticals from 2009 to 2012 where he led research programs for the biology group, including developing strategies to evaluate its proprietary oligonucleotides as therapeutic agents for the treatment of hematological malignancies, autoimmune diseases and as vaccine adjuvants. From 1991 to 2009, he worked at the Istituto di Ricerche di Biologia Molecolare (IRBM), Rome, Italy, a research site of Merck Research Laboratories. His most recent position was Director of Antiviral. Prior to that, he held the positions of Director of Oncology and Director of Cancer Immunology and Genomics. Nicola earned his BA degree in Biology from the University of Rochester in 1982. His graduate studies were completed at Columbia University, where he earned a PhD in Microbiology in 1988.
If we want things to stay as they are, things will have to change.
Giuseppe Tommasi di Lampedusa, The Leopard
I am a "strong" supporter of the Italian National soccer team